Stock Events

Stock Events

Search...

Brainstorm Cell Therapeutics (BCLI) Q4 2024 Earnings

14NovConfirmed

Q3 2023

Q2 2024

Q3 2024

Q4 2024

-0.58

-0.18

0.21

0.6

Details

Expected EPS

-0.575

Actual EPS

-0.51

Surprise EPS

0.06

Surprise Percent

+11.3%

Description

Brainstorm Cell Therapeutics (BCLI) has reported earnings of -0.51 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.